No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RMD241220C240000
- 0.22
- -0.93-80.87%
15min DelayClose Dec 19 16:00 ET
0.25High0.10Low
0.15Open1.15Pre Close10 Volume161 Open Interest240.00Strike Price183.00Turnover75.86%IV3.73%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type0.0826Delta0.0258Gamma1052.64Leverage Ratio-1.0653Theta0.0002Rho86.98Eff Leverage0.0118Vega
Intraday
- 5D
- Daily
News
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
With 74% Institutional Ownership, ResMed Inc. (NYSE:RMD) Is a Favorite Amongst the Big Guns
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Stifel Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $250
ResMed Analyst Ratings